Abstract
Development of invasive aspergillosis correlates with impairments in innate immunity. We and others have recently shown that arachidonic acid metabolism pathways, specifically the cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) pathways, participate in the induction of protective innate immune responses during invasive aspergillosis. Based on the high degree of cooperation and interconnection within the eicosanoid network, we hypothesized that 12/15-LOX is also active during invasive aspergillosis. We report in this study that mice deficient in the gene encoding 12/15-LOX (Alox15) are profoundly susceptible to invasive aspergillosis. Decreased survival correlated with increased fungal burden and evidence of increased lung damage. These defects were associated with very early (6 and 12 h) 12/15-LOX-dependent inflammatory cytokine (IL-1α, IL-1β, and TNF-α) and chemokine (CCL3 and CCL4) production. Neutrophil levels in the lung were blunted in the absence of 12/15-LOX, although neutrophil antifungal activity was intact. However, lower neutrophil levels in the lungs of Alox15−/− mice were not a result of impaired recruitment or survival; rather, Alox15−/− mice demonstrated impaired neutrophil granulopoiesis in the bone marrow intrinsically and after fungal exposure. Employing a lower inoculum to allow for better survival allowed the identification of 12/15-LOX-dependent induction of IL-17A and IL-22. Impaired IL-17A and IL-22 production correlated with reduced invariant NKT cell numbers as well as lower IL-23 levels. Together, these data indicate that 12/15-LOX is a critical player in induction of the earliest aspects of the innate immune response to Aspergillus fumigatus.
Conidia of the opportunistic fungal pathogen Aspergillus fumigatus are sufficiently small and buoyant to reach the lower respiratory tract and have the potential to germinate into large, tissue-destructive hyphae. Immunodeficiencies leading to failure of the innate immune processes that normally control this growth may result in several conditions, the most severe being invasive aspergillosis (IA). In IA, uncontrolled Aspergillus growth results in tissue damage and potential dissemination to other organs. Some progress has been made in reducing fatality rates in groups at increased risk for IA, including solid organ transplant recipients and hematological malignancy patients, although current rates still exceed 20% for both groups (1, 2). Current prophylactic antifungal protocols have failed to effectively prevent infections in these groups (3, 4). The ability to target or activate necessary host defense pathways without disrupting the primary treatment modality may improve outcomes. In addition to traditional risk concerns, a newer concern is that climate change may increase the risk of infection by fungal pathogens because of increased selection for thermotolerant species, more exposure during extreme weather events, and increased fungal growth in the environment overall (5, 6).
The eicosanoid class of bioactive lipids are major players in numerous mammalian systems, including the immune system (7). The immunological functions of eicosanoid pathways are of interest, as players in the innate response in the lung because of their rapid action and ability to both drive and resolve inflammation. Distinct eicosanoid species number in the hundreds but belong to a relatively small number of major pathways anchored by key upstream enzymes including cyclooxygenase (COX)-1 and COX-2 and 5-lipoxygenase (LOX) and 12/15-LOX (8). Regarding IA, recent research in our laboratory identified COX-2 as a driver of multiple critical cytokines including IL-17A and IL-22 during IA (9). Another recent report recognized the crucial role of 5-LOX in neutrophil and eosinophil recruitment during IA (10). Interaction between various COX and LOX pathways is a distinguishing feature of eicosanoid biology (8). Thus, the discovery of important roles of COX-2 and 5-LOX during IA begs the question of the function of closely related enzymes, including 12/15-LOX.
12/15-LOX has the biosynthetic capacity to produce multiple families of eicosanoids including proinflammatory hydroxyeicosatetraenoic acids (HETEs) and hepoxilins as well as anti-inflammatory or proresolution resolvins, protectins, and, in cooperation with 5-LOX, lipoxins (11). Investigations of 12/15-LOX during lung infection have primarily associated proresolution products of 12/15-LOX with improved outcomes and proinflammatory products with negative outcomes. Increased levels of the lipoxin A4 receptor Alx/Fpr2 were associated with improved clearance of the fungal pathogen Cryptococcus neoformans (12). Administration of Resolvin E1 increased bacterial clearance and survival in a model of aspiration pneumonia (13). Conversely, during Streptococcus infection 12/15-LOX and its proinflammatory product hepoxilin A3 contributed to bacteremia and host death via promotion of neutrophil migration and an associated increase in epithelial permeability (14). In the current report, we describe a role for 12/15-LOX in promotion of protective inflammatory responses, including neutrophil granulopoiesis and cytokine production, which are required for survival and fungal clearance during experimental IA.
Materials and Methods
Mice
Male and female, age-matched C57BL/6 mice, 6–8 wk of age, were obtained from The Jackson Laboratory (Bangor, ME). Male and female, age-matched Alox15−/− mice were obtained from The Jackson Laboratory (B6.129S2-Alox15tm1Fun/J, stock no. 002778) and bred at Tulane University. All animals were housed in a specific pathogen-free, Association for Assessment and Accreditation of Laboratory Animal Care-certified facility and handled according to Public Health Service Office of Laboratory Animal Welfare policies after review by the Tulane Institutional Animal Care and Use Committee.
Preparation of A. fumigatus: in vivo challenge and lung fungal burden assessment
A. fumigatus isolate 13073 (American Type Culture Collection, Manassas, VA) was maintained on potato dextrose agar for 5–7 d at 37°C. Conidia were harvested by washing the culture flask with 50 ml of sterile PBS supplemented with 0.1% Tween 20. The conidia were then passed through a sterile 40-μm nylon membrane to remove hyphal fragments and enumerated on a hemacytometer. For challenge, mice were lightly anesthetized with isoflurane and administered 7 × 107 A. fumigatus conidia in a volume of 50 μl intratracheally as previously described (15, 16). Briefly, mice are held in a vertical, upright position, and the tongue is withdrawn from the mouth using forceps. A pipette is used to deliver the 50 μl inoculum to the caudal oropharynx, where normal breathing results in fluid aspiration into the lungs (17). For lung fungal burden analysis, the left lungs were collected at 48 h postexposure and homogenized in 1 ml of PBS. Total RNA was extracted from 0.1 ml of unclarified lung homogenate using the MasterPure Yeast RNA Purification Kit (Epicentre Biotechnologies, Madison, WI), which includes a DNase treatment step to eliminate genomic DNA as previously reported (18). Total RNA was also extracted from serial 1:10 dilutions of live A. fumigatus conidia (1 × 101–1 × 109) and DNase treated to form a standard curve. Lung A. fumigatus burden was analyzed with real-time PCR measurement of the A. fumigatus 18S rRNA (19) and quantified using a standard curve of A. fumigatus conidia as previously described (18). As a validation of the real-time PCR method, heat-killed A. fumigatus did not yield a signal by real-time PCR and were unable to grow on potato dextrose agar plates (18). In addition, no amplification controls (i.e., no reverse transcriptase included in the cDNA reaction) yielded a signal of <0.001% by real-time PCR, indicating that the DNase treatment step efficiently eliminated contaminating A. fumigatus DNA [as DNA is not predicative of organism viability (20)].
12-HETE analysis
Bronchoalveolar lavage was performed as previously described (21). 12-HETE levels were quantified using 12(S)-HETE ELISA Kit (catalog no. ADI-900-050) per the manufacturer’s instructions (Enzo Life Sciences, Farmingdale, NY).
Inflammatory cytokine analysis
Mice were anesthetized with i.p. ketamine/xylazine and sacrificed by exsanguination at various time points postinfection. Both lungs were collected and minced in IMDM media (Sigma-Aldrich, St. Louis, MO) supplemented with 1% penicillin-streptomycin-glutamine (Mediatech, Herndon, VA), 10% heat-inactivated FBS (Invitrogen, Carlsbad, CA), and 0.4 mg/ml polymyxin B (Thermo Fisher Scientific), followed by incubation for 60 min with tissue culture-grade type IV collagenase (1 mg/ml; MilliporeSigma, St. Louis, MO) in a 37°C orbital shaker at 100 Rpm. The cell suspension was filtered through sterile 70- and 40-μm nylon filters and RBCs lysed with ammonium-chloride-potassium (ACK) buffer (Lonza, Walkersville, MD) to create lung cell digest preparations. For lung cell cultures, cells were enumerated on a hemacytometer and plated at 1 × 106 cells in a volume of 0.2 ml. Supernatants were collected after 24 h, clarified by centrifugation and stored at −80°C. Supernatants were analyzed for protein levels of 32 cytokines and chemokines using a MILLIPLEX Multiplex Suspension Cytokine Array (MilliporeSigma) according to the manufacturer’s instructions. The data were analyzed using Bio-Plex Manager Software (Bio-Rad Laboratories, Hercules, CA). IL-23 and IL-22 levels were quantified by ELISA (R&D Systems). Serum was isolated using BD Microtainer Tubes (365967) according to the manufacturer’s instructions. G-CSF levels were quantified by MILLIPLEX assay or ELISA (R&D Systems, Minneapolis, MN).
Flow cytometry
Lung cells were isolated previously as described above. Cells were washed, and Fc receptors were blocked with Mouse BD Fc Block (BD Biosciences, San Diego, CA) at 4°C for 20 min. Thereafter, cells were stained with a single-color LIVE/DEAD Fixable Dead Cell Stain (Invitrogen, Carlsbad, CA), followed by labeling with specific immune cell surface markers. The following staining parameters were employed: eosinophils as CD11b+ Siglec F+ Ly-6G−, neutrophils as CD11b+ Ly-6G+, inflammatory monocytes as CD11b+ Ly-6C+ CCR2+, invariant NKT (iNKT) cells as PBS57-labeled CD1d tetramer+, γδ T cells as γδ TCR+ CD3+ (all Abs purchased from BioLegend, eBioscience, and BD Biosciences; CD1d tetramer from National Institutes of Health Tetramer Core Facility, Emory University, Atlanta, GA). Bone marrow cells were isolated from one femur and tibia of naive or infected mice (22). Briefly, bones were harvested, cleaned of tissue, then centrifuged at 10,000 × g for 15 s to pellet bone marrow cells. Cell pellets were treated with ACK buffer to lyse RBCs and filtered through 40-μm nylon filters. Spleens were harvested, pushed through a 70-μm filter with a 3-ml syringe plunger, treated with ACK buffer, and subsequently filtered through a 40-μm filter. Blood was drawn from the inferior vena cava into blood collection tubes containing EDTA and lysed with ACK buffer. Analysis of PMN progenitor populations was performed as described (23). Briefly, dead cells and cells expressing CD3, CD4, CD8, B220, or Ter119 were excluded as well as side scatter-high, forward scatter-intermediate, and c-KithiCD34low populations. Neutrophil precursors were then analyzed based on expression of c-Kit and Ly-6G.
Lung injury assessment
A bronchoalveolar lavage was performed as previous described (21). Total protein levels were quantified using a Pierce BCA Protein Assay Kit. Lactate dehydrogenase levels were quantified using CytoTox 96 Non-Radioactive Cytotoxicity Assay (Promega, Madison, WI) per manufacturer’s instructions.
Assessment of in vitro A. fumigatus killing
Neutrophils were isolated from the peritoneal cavity via thioglycolate elicitation as we have previously described (15). For A. fumigatus killing in vitro, neutrophils (1 × 105) were cocultured at a 1:1 E:T ratio with live A. fumigatus swollen conidia for 24 h, followed by RNA isolation with the MasterPure Yeast RNA Purification Kit and real-time PCR assessment as described above. Controls included A. fumigatus swollen conidia cultured in the absence of neutrophils for 24 h. Alveolar macrophages were isolated by bronchoalveolar lavage as previously described (21) and cultured with resting conidia as above with neutrophils and analyzed similarly.
Histology
The left lungs were collected and fixed in 4% formalin. The fixed lungs were paraffin embedded and then processed and stained by GNO Histology Consultants (New Orleans, LA). Imaging was performed using a Swift Optical Instruments M10T-P Trinocular LED Microscope equipped with a Motic Moticam 5+ 5 megapixel digital camera. The total number of organisms and number of germinated organisms were counted from two randomly selected fields per animal to compute percent germination.
Statistics
Data were analyzed using GraphPad Prism Version 5.0 statistical software. Comparisons between groups when data were normally distributed were made with the Student t test. Significance was accepted at a p value < 0.05.
Results
12/15-LOX deficiency results in profound mortality during A. fumigatus lung infection
We have recently reported that in vivo pharmacologic inhibition of COX-2 results in impaired elimination of A. fumigatus from the lung (9). This correlated with a significant reduction in the production of multiple proinflammatory mediators previously reported to be required for fungal clearance (9). Another recent study reported that mice deficient in 5-LOX, which functions as a COX-2-independent arachidonic acid metabolism pathway leading to the generation of leukotrienes, exhibited decreased survival in response to a highly virulent A. fumigatus strain, but was dispensable for protection when challenged with a less-virulent strain (10). 12/15-LOX is an additional COX-2 independent arachidonic acid metabolism pathway (docosahexaenoic acid and linoleic acid may also serve as 12/15-LOX substrates) that generates lipoxins, resolvins, and protectins (11). Initial studies show that 12-HETE, a major product of 12/15-LOX activity, is rapidly induced in the lung after A. fumigatus exposure in a 12/15-LOX-dependent manner (Fig. 1A). Lung exposure to A. fumigatus resulted in rapid mortality in 12/15-LOX-deficient mice (Alox15−/−), with nearly a third of the mice succumbing to infection within 36 h and only 20% of mice surviving by 72 h (Fig. 1B). The survival defect was apparent in both male and female mice (data not shown). Thus, 12/15-LOX is essential for survival after acute challenge with A. fumigatus.
The absence of 12/15-LOX results in impaired fungal clearance and increased lung damage during A. fumigatus lung infection
Based on the observation that 12/15-LOX-deficient mice demonstrated rapid and significant mortality after lung challenge with A. fumigatus, we hypothesized that these mice had difficulty clearing A. fumigatus from the lungs. Although lung fungal burden was similar 6 h after A. fumigatus challenge, Alox15−/− mice demonstrated a 4-fold and 7-fold higher fungal burden at 12 and 24 h after exposure, respectively (Fig. 2A). Grocott-Gomori’s methenamine silver staining of lung tissues also indicated higher numbers of A. fumigatus organisms in Alox15−/− mice (Fig. 2B) as well as more germinating organisms (Fig. 2C). As germinating organisms can augment lung injury, we further show that total protein (Fig. 2D), a measure of lung leakage, and lactate dehydrogenase (Fig. 2E), a measure of lung cell damage/death, levels were elevated in lavage fluid from 12/15-LOX-deficient mice 24 h postexposure. These data suggest that mortality associated with 12/15-LOX deficiency is a result of lung damage induced by elevated fungal burden.
12/15-LOX is required for early inflammatory responsiveness during A. fumigatus lung infection
A. fumigatus exposure results in the induction of multiple proinflammatory responses that are required for pathogen elimination (24–26). However, in some instances, these proinflammatory responses may complicate fungal clearance (27, 28). As demonstrated earlier, fungal clearance was impaired in Alox15−/− mice as early as 12 h after A. fumigatus exposure, suggesting that 12/15-LOX was critical for an early proinflammatory response that promoted inflammatory cell recruitment. To this end, results show that by 6 h after A. fumigatus challenge, Alox15−/− mice had significant reductions in IL-1α (Fig. 3A), IL-1β (Fig. 3B), TNF-α (Fig. 3C), CCL3 (Fig. 3D), and CCL4 (Fig. 3E). IL-1α, IL-1β, and CCL4 levels in Alox15−/− mice remained lower 12 h after A. fumigatus exposure. By 24 h after challenge, however, multiple mediators were increased in Alox15−/− mice, likely as a result of the heightened fungal burden (CCL3 and CCL4 in particular, levels of which were often beyond the limit of detection in our assay). CXCL1 was not increased over naive levels, whereas CXCL2 was not different between wild-type (WT) and Alox15−/− (data not shown). Taken together, these data suggest that 12/15-LOX is required for the optimal early induction of proinflammatory cytokines and chemokines that support neutrophil recruitment to the lung during A. fumigatus infection.
12/15-LOX is required for inflammatory cell recruitment during A. fumigatus lung infection
Neutrophils are a vital component of the innate immune response to IA. Neutropenia, defective recruitment to infected tissues or the inability of neutrophils to mediate antifungal activities are well-recognized contributors to the development of IA (29). We rationalized that the development of IA in 12/15-LOX-deficient mice was a result of impaired neutrophil recruitment or activity. Indeed, as early as 6 h after A. fumigatus challenge, a time point in which fungal burden was similar between WT and Alox15−/− mice (Fig. 2), we observed 5-fold lower numbers of neutrophils in the lungs of Alox15−/− mice (Fig. 4A). This defect in lung neutrophil levels was maintained through 12 and 24 h after A. fumigatus challenge (Fig. 4A). Studies by us and others have previously identified antifungal roles for eosinophils (30) and inflammatory monocytes (31) in innate immune clearance of A. fumigatus. Eosinophil recruitment was dependent on 12/15-LOX at 6 and 12 h after A. fumigatus challenge but was restored to WT levels by 24 h (Fig. 4B). In contrast, we observed no dependency on 12/15-LOX for inflammatory monocyte recruitment at any time point (Fig. 4C). Of note, lung neutrophils, but not eosinophils and inflammatory monocytes, were significantly lower in naive Alox15−/− mice (Fig. 4A–C). Despite lower numbers in the lungs, Alox15−/− neutrophils did not demonstrate an impairment in in vitro antifungal activity (Fig. 4D). Unexpectedly, however, alveolar macrophages from naive Alox15−/− mice had enhanced antifungal activity against A. fumigatus (Fig. 4E), suggesting that 12/15-LOX plays a restrictive role in macrophage antifungal activity. H&E staining confirmed the profound reduction in inflammatory cell infiltration in the lungs of 12/15-LOX-deficient mice (Fig. 4F). Collectively, 12/15-LOX is required for optimal neutrophil numbers in the lung; however, it is dispensable for neutrophil antifungal activity. Moreover, increased antifungal activity by alveolar macrophages is not sufficient to compensate for the reduced neutrophil numbers in the lung in Alox15−/− mice.
12/15-LOX is required for neutrophil granulopoiesis during A. fumigatus lung infection
We speculated that lower induction of proinflammatory cytokines and chemokines (Fig. 3) was likely responsible for the observed reduction in neutrophils in the lungs of Alox15−/− mice. However, we also observed reduced neutrophil numbers in the blood (Fig. 5A) and bone marrow (Fig. 5B) from Alox15−/− mice 6 h after A. fumigatus challenge. This observation suggested the possibility that neutrophil survival, which is controlled by G-CSF, may be impaired in Alox15−/− mice. However, G-CSF levels in serum from naive Alox15−/− mice was comparable to naive WT mice and even slightly increased by 6 h after A. fumigatus challenge (Fig. 5C). To further understand lower neutrophil levels in multiple compartments in Alox15−/− mice, we examined granulocyte differentiation via c-Kit and Ly-6G expression in the bone marrow. During the five-stage process of granulocyte differentiation and acquisition of granule contents, granulocytes acquire Ly-6G expression and gradually lose the expression of c-Kit (23). We found that 6 h after A. fumigatus challenge, Alox15−/− mice had similar numbers of myeloblasts, promyelocytes, and myelocytes (stages 1, 2, and 3) compared with WT mice (Fig. 5D). In contrast, metamyelocytes (stage 4) and mature neutrophils (stage 5) were significantly lower in Alox15−/− mice compared WT mice (Fig. 5D). Defective neutrophil maturation in the bone marrow was intrinsic to Alox15−/− mice, as naive mice also demonstrated lower numbers of myelocytes, metamyelocytes, and mature neutrophils (Fig. 5E). Taken together, these results suggest that impaired neutrophil levels in the lungs of Alox15−/− mice are a result of 12/15-LOX-dependent neutrophil granulopoiesis in the bone marrow rather than a defect in recruitment or survival.
Type 17 responses during A. fumigatus lung infection are dependent on 12/15 LOX
We have previously reported that IL-17A and IL-22 are critical for lung defense during IA (15, 16). Recently, we have reported that iNKT cells and γδ T cells are the primary sources of IL-22 during IA (32) and hypothesize that these cell types may also serve as lung cell sources of IL-17A. We have shown that IL-22 production peaks in the lung 48 h after A. fumigatus challenge (32). To determine the impact of 12/15-LOX on type 17 (IL-17A and IL-22) responses during IA, we challenged mice with a lower inoculum, thus allowing for detection of IL-17A and IL-22 at time points between 36 and 48 h. Results demonstrated that IL-17A (Fig. 6A) and IL-22 (Fig. 6B) were highly dependent on 12/15-LOX. To further investigate mechanisms associated with lower levels of IL-17A and IL-22, we examined the presence of innate-like lymphocytes in the lung, which demonstrated reduced numbers of iNKT cells (Fig. 6C), but not γδ T cells (Fig. 6D). Reduced iNKT cell numbers did not correlate with reductions in CCL17 (data not shown), a chemokine implicated in iNKT cell extravasation from the vasculature to the lung (33). Finally, we also observed lower levels of IL-23, which we have previously reported as a central upstream mediator of type 17 responses (15, 16), in the lungs of Alox15−/− mice after A. fumigatus challenge (Fig. 6E). Thus, 12/15-LOX is critical for induction of type 17 responses during IA, likely through the induction of IL-1β and IL-23.
Discussion
Detailed understanding of how the innate immune system deploys and organizes the response to A. fumigatus in normal hosts is fundamental to developing new immune-based therapies against IA. Of particular interest regarding the lung, resolution of the inflammatory response is nearly as important as induction of inflammation in terms of a successful response to infection. Arachidonic acid is a polyunsaturated fatty acid released from the cell membrane by phospholipases in response to various inflammatory conditions (34). Cyclooxygenases, cytochrome P450 mono-oxygenases, and LOXs are the enzymes involved in the oxidative metabolism of arachidonic acid, the latter of which leads to the production of leukotrienes, hydroperoxyeicosatetraenoic acids, HETEs, and hydroxyoctadecadienoic acids (35). The major LOXs in humans include 5-LOX, 12-LOX (platelet and leukocyte forms), and 15-LOX (reticulocyte and leukocyte forms), although leukocyte 12-LOX and reticulocyte 15-LOX form similar products and, thus, are usually referred to as 12/15-LOX (35). Mice express 5-LOX and 12/15-LOX (leukocyte 12-LOX), which is encoded by the Alox15 gene and is considered orthologous to human 12/15-LOX. Select lipid species, such as lipoxin A4 produced by 12/15-LOX, have noted proresolution functions and are thought to be produced later in a given response in an effort to temper inflammation and damage (36). Recent reports have demonstrated that diverse arachidonic acid metabolism pathways, specifically the induction of COX-2 and 5-LOX, are critical components of the acute inflammatory response to A. fumigatus in the lung (9, 10). In this study, we interrogated the role of the 12/15-LOX pathway in regulating the immune response to a highly inflammatory opportunistic mold.
Our initial findings revealed that Alox15−/− mice were profoundly susceptible to mortality after lung exposure to A. fumigatus, demonstrating ~20% survival within 72 h postchallenge. This level of susceptibility rivals what we have previously reported for mice deficient in Dectin-1, a β-glucan-specific pattern recognition receptor required for lung defense against A. fumigatus (15), and was more severe than that recently reported for 5-LOX-deficient mice (10). We primarily attributed mortality in Alox15−/− mice to impaired lung fungal clearance, as fungal burden was >7-fold higher in deficient mice by 24 h. Grocott-Gomori’s methenamine silver staining of lung tissue suggested increased fungal germination in the alveolar space, and along with enhanced fungal burden, these observations corresponded with markers of lung injury. Immunologic assessments correlating with defective fungal clearance in Alox15−/− mice included defective IL-1α and IL-1β production. Renewed interest in the IL-1 family of cytokines has uncovered novel roles for IL-1α and IL-1β in lung defense during acute A. fumigatus exposure (24, 25). Although we have previously reported that IL-1α is dependent on IL-22 after acute A. fumigatus exposure (16), we have also recently reported that signaling through the IL-1R is required for optimal IL-22 production after A. fumigatus exposure (9). IL-1α is thought to mediate protection via CXCL1-dependent neutrophil recruitment (24). Although CXCL1 levels were not induced over the levels observed in naive mice, we instead observed defective production of the neutrophil attracting chemokines CCL3 and CCL4. Mice deficient in CCR1, the receptor for CCL3 and CCL4, display defective neutrophil recruitment to the lung and decreased survival after A. fumigatus challenge, highlighting the importance of CCL3 and CCL4 signaling during IA (37). Moreover, our previous work has demonstrated reduced neutrophil recruitment in the presence of impaired TNF-α, CCL3, and CCL4 production in Dectin-1-deficient mice during IA (15). Furthermore, we have shown that TNF-α, CCL3, and CCL4 production are impaired in IL-22-deficient mice, which also demonstrate impaired neutrophil recruitment and increased susceptibility to IA (16). Collectively, defective induction of the IL-1α/IL-1β, TNF-α, and CCL3/CCL4 axes in the initial hours following A. fumigatus are likely major contributors to the overall susceptibility of Alox15−/− mice to IA. Ongoing studies in our laboratory are investigating the relationship between pattern recognition receptor recognition of A. fumigatus and activation of 12/15-LOX and related pathways to promote the inflammatory responses we report in this study.
Despite the fact that the IL-1α/IL-1β, TNF-α, and CCL3/CCL4 axes play a role in neutrophil recruitment to the lungs during A. fumigatus infection and the fact that these axes are 12/15-LOX dependent, our data suggest a more compelling role for 12/15-LOX in neutrophil responses during A. fumigatus infection. Previous reports have shown that naive, 6–8-wk-old Alox15−/− mice have no major differences in the levels of immune cell populations in bone marrow and blood (38, 39). In contrast, other studies have reported that naive Alox15−/− mice at ~15 wk of age have changes in splenic immune cell populations, specifically decreased lymphocytes and monocytes, increased basophils, but no differences in neutrophils (40). However, a follow-up study by the same group reported that naive Alox15−/− mice had evidence for paradoxically enhanced granulopoiesis (increased Ly-6G+ cells and increased GMPs in the bone marrow) (41). In contrast, similar to our 6 h infection data, we observed that naive Alox15−/− mice (at 6–8 wk old, which were employed for all studies in the current body of work) demonstrated lower levels of myelocytes (stage 3), metamyelocytes (stage 4), and mature neutrophils (stage 5) in the bone marrow. Other models of lung infection with Mycobacterium tuberculosis (42) and Streptococcus pneumoniae (14) have reported reductions in lung neutrophil numbers in Alox15−/− mice; however, these reports hypothesized that lower levels of neutrophils were a result of impaired recruitment. Although the M. tuberculosis study (42) performed bone marrow chimera studies and demonstrated lower neutrophils in the lungs of M. tuberculosis-infected mice receiving Alox15−/− bone marrow, their interpretation was that Alox15 expression in a hematopoietic cell was required for neutrophil recruitment to the lungs during infection. With our study investigating neutrophils levels in the bone marrow of both naive and infected mice as well as the numbers of specific neutrophil precursors, it is, to our knowledge, the first to suggest that lower neutrophil numbers during lung infection may be the result of failed neutrophil granulopoiesis in the bone marrow of Alox15−/− mice rather than failed recruitment or survival.
The cytokines IL-17A and IL-22 promote microbial clearance via the induction of chemokines that support neutrophil recruitment as well as the elicitation of antimicrobial factors from the epithelium (43). We have shown in numerous reports the importance of IL-17A and IL-22 in lung defense against A. fumigatus (15, 16, 44). However, these studies were conducted using our standard inoculum for nonimmunosuppressed mice. At this concentration, Alox15−/− mice did not survive to the time point in which we have reported IL-17A and IL-22 to be maximally expressed (i.e., 36–48 h) (32); thus, we were unable to thoroughly investigate the impact of the 12/15-LOX pathway on IL-17A/IL-22 responses. However, by lowering the inoculum, we were able to document that IL-17A and IL-22 production were 12/15-LOX dependent. Results explaining the defect in IL-17A and IL-22 production showed that IL-23, an upstream positive regulator we have shown to be required for IL-17A (44) and IL-22 (16) during IA, was partially 12/15-LOX dependent. We have recently reported that innate-like lymphocytes, specifically iNKT cells and γδ T cells, are the primary cell sources of IL-22 (and likely IL-17A) in the lung during IA (32). An additional mechanism of lower IL-17A and IL-22 has fewer iNKT cell, but not γδ T cell, numbers in the lungs of Alox15−/− mice. Based on observing lower numbers of iNKT cells in the spleen of naive Alox15−/− mice (data not shown) and intact levels of the iNKT chemokine CCL17 (data not shown) in the lung during IA, it is tempting to speculate whether iNKT cell development as opposed to 12/15-LOX-mediated recruitment is impaired in Alox15−/− mice during infection. Our findings extend observations in the gut, showing lower IL-17A levels in Alox15−/− mice during peritonitis (45), likely as a result of impaired macrophage-derived IL-23 production (46).
In many lung model systems, the initial inflammatory wave is characterized by COX-2-mediated PGE2 and 5-LOX-mediated leukotriene production in concert with neutrophil recruitment (47). As inflammation ensues, 12/15-LOX-mediated pathways are engaged to drive resolution of the inflammatory response via specialized proresolving mediators (lipoxins, resolvins, protectins, and maresins). Our data points to a requirement for 12/15-LOX activity in the induction of very early antifungal innate immune response following exposure to A. fumigatus, namely inflammatory cytokine and chemokine induction. Strikingly, however, our data uncover a new role for 12/15-LOX in driving neutrophil granulopoiesis in the bone marrow. As these responses occur within hours after fungal exposure, we conclude that 12/15-LOX has a conclusive proinflammatory role in the acute inflammatory response to A. fumigatus. To this end, our study provides new insight into signaling events catalyzing early innate immune activity during invasive lung fungal infections.
Acknowledgments
This work was supported was supported by National Institutes of Health Grants HL122426 and HL136211.
Abbreviations used in this article:
- ACK
ammonium-chloride-potassium
- HETE
hydroxyeicosatetraenoic acid
- IA
invasive aspergillosis
- iNKT
invariant NKT
- LOX
lipoxygenase
- WT
wild-type
Footnotes
Disclosures
The authors have no financial conflicts of interest.
References
- 1.Lemonovich TL 2018. Mold infections in solid organ transplant recipients. Infect. Dis. Clin. North Am 32: 687–701. [DOI] [PubMed] [Google Scholar]
- 2.Dragonetti G, Criscuolo M, Fianchi L, and Pagano L. 2017. Invasive aspergillosis in acute myeloid leukemia: are we making progress in reducing mortality? Med. Mycol 55: 82–86. [DOI] [PubMed] [Google Scholar]
- 3.van de Peppel RJ, Visser LG, Dekkers OM, and de Boer MGJ. 2018. The burden of Invasive Aspergillosis in patients with haematological malignancy: a meta-analysis and systematic review. J. Infect 76: 550–562. [DOI] [PubMed] [Google Scholar]
- 4.Baker AW, Maziarz EK, Arnold CJ, Johnson MD, Workman AD, Reynolds JM, Perfect JR, and Alexander BD. 2020. Invasive fungal infection after lung transplantation: epidemiology in the setting of antifungal prophylaxis. Clin. Infect. Dis 70: 30–39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Garcia-Solache MA, and Casadevall A. 2010. Global warming will bring new fungal diseases for mammals. MBio 1: e00061–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Knutsen AP, Bush RK, Demain JG, Denning DW, Dixit A, Fairs A, Greenberger PA, Kariuki B, Kita H, Kurup VP, et al. 2012. Fungi and allergic lower respiratory tract diseases. J. Allergy Clin. Immunol 129: 280–291, quiz 292–293. [DOI] [PubMed] [Google Scholar]
- 7.Esser-von Bieren J 2017. Immune-regulation and -functions of eicosanoid lipid mediators. Biol. Chem 398: 1177–1191. [DOI] [PubMed] [Google Scholar]
- 8.Dennis EA, and Norris PC. 2015. Eicosanoid storm in infection and inflammation. [Published erratum appears in 2015 Nat. Rev. Immunol 15: 724.] Nat. Rev. Immunol. 15: 511–523. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Garth JM, Reeder KM, Godwin MS, Mackel JJ, Dunaway CW, Blackburn JP, and Steele C. 2017. IL-33 signaling regulates innate IL-17A and IL-22 production via suppression of prostaglandin E2 during lung fungal infection. [Published erratum appears in 2017 J. Immunol 199: 3381.] J. Immunol. 199: 2140–2148. [DOI] [PubMed] [Google Scholar]
- 10.Caffrey-Carr AK, Hilmer KM, Kowalski CH, Shepardson KM, Temple RM, Cramer RA, and Obar JJ. 2018. Host-derived leukotriene B4 is critical for resistance against invasive pulmonary aspergillosis. Front. Immunol 8: 1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Ackermann JA, Hofheinz K, Zaiss MM, and Krönke G. 2017. The double-edged role of 12/15-lipoxygenase during inflammation and immunity. Biochim Biophys Acta Mol Cell Biol Lipids 1862: 371–381. [DOI] [PubMed] [Google Scholar]
- 12.Colby JK, Gott KM, Wilder JA, and Levy BD. 2016. Lipoxin signaling in murine lung host responses to Cryptococcus neoformans infection. Am. J. Respir. Cell Mol. Biol 54: 25–33. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Seki H, Fukunaga K, Arita M, Arai H, Nakanishi H, Taguchi R, Miyasho T, Takamiya R, Asano K, Ishizaka A, et al. 2010. The anti-inflammatory and proresolving mediator resolvin E1 protects mice from bacterial pneumonia and acute lung injury. J. Immunol 184: 836–843. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Bhowmick R, Maung N, Hurley BP, Ghanem EB, Gronert K, McCormick BA, and Leong JM. 2013. Systemic disease during Streptococcus pneumoniae acute lung infection requires 12-lipoxygenase-dependent inflammation. J. Immunol 191: 5115–5123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Werner JL, Metz AE, Horn D, Schoeb TR, Hewitt MM, Schwiebert LM, Faro-Trindade I, Brown GD, and Steele C. 2009. Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J. Immunol 182: 4938–4946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Gessner MA, Werner JL, Lilly LM, Nelson MP, Metz AE, Dunaway CW, Chan YR, Ouyang W, Brown GD, Weaver CT, and Steele C. 2012. Dectin-1-dependent interleukin-22 contributes to early innate lung defense against Aspergillus fumigatus. Infect. Immun 80: 410–417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Nemzek JA, Ebong SJ, Kim J, Bolgos GL, and Remick DG. 2002. Keratinocyte growth factor pretreatment is associated with decreased macrophage inflammatory protein-2alpha concentrations and reduced neutrophil recruitment in acid aspiration lung injury. Shock 18: 501–506. [DOI] [PubMed] [Google Scholar]
- 18.Mattila PE, Metz AE, Rapaka RR, Bauer LD, and Steele C. 2008. Dectin-1 Fc targeting of aspergillus fumigatus beta-glucans augments innate defense against invasive pulmonary aspergillosis. Antimicrob. Agents Chemother 52: 1171–1172. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Bowman JC, Abruzzo GK, Anderson JW, Flattery AM, Gill CJ, Pikounis VB, Schmatz DM, Liberator PA, and Douglas CM. 2001. Quantitative PCR assay to measure Aspergillus fumigatus burden in a murine model of disseminated aspergillosis: demonstration of efficacy of caspofungin acetate. Antimicrob. Agents Chemother 45: 3474–3481. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Hummel M, Spiess B, Roder J, von Komorowski G, Dürken M, Kentouche K, Laws HJ, Mörz H, Hehlmann R, and Buchheidt D. 2009. Detection of Aspergillus DNA by a nested PCR assay is able to improve the diagnosis of invasive aspergillosis in paediatric patients. J. Med. Microbiol 58: 1291–1297. [DOI] [PubMed] [Google Scholar]
- 21.Lilly LM, Gessner MA, Dunaway CW, Metz AE, Schwiebert L, Weaver CT, Brown GD, and Steele C. 2012. The β-glucan receptor dectin-1 promotes lung immunopathology during fungal allergy via IL-22. J. Immunol 189: 3653–3660. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Amend SR, Valkenburg KC, and Pienta KJ. 2016. Murine hind limb long bone dissection and bone marrow isolation. J. Vis. Exp e53936. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Satake S, Hirai H, Hayashi Y, Shime N, Tamura A, Yao H, Yoshioka S, Miura Y, Inaba T, Fujita N, et al. 2012. C/EBPβ is involved in the amplification of early granulocyte precursors during candidemia-induced “emergency” granulopoiesis. J. Immunol 189: 4546–4555. [DOI] [PubMed] [Google Scholar]
- 24.Caffrey AK, Lehmann MM, Zickovich JM, Espinosa V, Shepardson KM, Watschke CP, Hilmer KM, Thammahong A, Barker BM, Rivera A, et al. 2015. IL-1α signaling is critical for leukocyte recruitment after pulmonary Aspergillus fumigatus challenge. PLoS Pathog. 11: e1004625. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Caffrey-Carr AK, Kowalski CH, Beattie SR, Blaseg NA, Upshaw CR, Thammahong A, Lust HE, Tang YW, Hohl TM, Cramer RA, and Obar JJ. 2017. Interleukin 1α is critical for resistance against highly virulent Aspergillus fumigatus isolates. Infect. Immun 85: e00661–17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Mehrad B, Strieter RM, and Standiford TJ. 1999. Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis. J. Immunol 162: 1633–1640. [PubMed] [Google Scholar]
- 27.Iannitti RG, Napolioni V, Oikonomou V, De Luca A, Galosi C, Pariano M, Massi-Benedetti C, Borghi M, Puccetti M, Lucidi V, et al. 2016. IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis. Nat. Commun 7: 10791. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.de Luca A, Smeekens SP, Casagrande A, Iannitti R, Conway KL, Gresnigt MS, Begun J, Plantinga TS, Joosten LA, van der Meer JW, et al. 2014. IL-1 receptor blockade restores autophagy and reduces inflammation in chronic granulomatous disease in mice and in humans. Proc. Natl. Acad. Sci. USA 111: 3526–3531. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Cunha C, Kurzai O, Löffler J, Aversa F, Romani L, and Carvalho A. 2014. Neutrophil responses to aspergillosis: new roles for old players. Mycopathologia 178: 387–393. [DOI] [PubMed] [Google Scholar]
- 30.Lilly LM, Scopel M, Nelson MP, Burg AR, Dunaway CW, and Steele C. 2014. Eosinophil deficiency compromises lung defense against Aspergillus fumigatus. Infect. Immun 82: 1315–1325. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Espinosa V, Jhingran A, Dutta O, Kasahara S, Donnelly R, Du P, Rosenfeld J, Leiner I, Chen CC, Ron Y, et al. 2014. Inflammatory monocytes orchestrate innate antifungal immunity in the lung. PLoS Pathog. 10: e1003940. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Reeder KM, Mackel JJ, Godwin MS, Dunaway CW, Blackburn JP, Patel RP, and Steele C. 2018. The role of common γ-chain cytokines in lung Interleukin-22 regulation after acute exposure to Aspergillus fumigatus. Infect. Immun 86: e00157–18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Thanabalasuriar A, Neupane AS, Wang J, Krummel MF, and Kubes P. 2016. iNKT cell emigration out of the lung vasculature requires neutrophils and monocyte-derived dendritic cells in inflammation. Cell Rep. 16: 3260–3272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Lambeau G, and Gelb MH. 2008. Biochemistry and physiology of mammalian secreted phospholipases A2. Annu. Rev. Biochem 77: 495–520. [DOI] [PubMed] [Google Scholar]
- 35.Dobrian AD, Lieb DC, Cole BK, Taylor-Fishwick DA, Chakrabarti SK, and Nadler JL. 2011. Functional and pathological roles of the 12- and 15-lipoxygenases. Prog. Lipid Res 50: 115–131. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Levy BD, Clish CB, Schmidt B, Gronert K, and Serhan CN. 2001. Lipid mediator class switching during acute inflammation: signals in resolution. Nat. Immunol 2: 612–619. [DOI] [PubMed] [Google Scholar]
- 37.Gao JL, Wynn TA, Chang Y, Lee EJ, Broxmeyer HE, Cooper S, Tiffany HL, Westphal H, Kwon-Chung J, and Murphy PM. 1997. Impaired host defense, hematopoiesis, granulomatous inflammation and type 1-type 2 cytokine balance in mice lacking CC chemokine receptor 1. J. Exp. Med 185: 1959–1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Sun D, and Funk CD. 1996. Disruption of 12/15-lipoxygenase expression in peritoneal macrophages. Enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein. J. Biol. Chem 271: 24055–24062. [PubMed] [Google Scholar]
- 39.Middleton MK, Zukas AM, Rubinstein T, Jacob M, Zhu P, Zhao L, Blair I, and Puré E. 2006. Identification of 12/15-lipoxygenase as a suppressor of myeloproliferative disease. J. Exp. Med 203: 2529–2540. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Kinder M, Wei C, Shelat SG, Kundu M, Zhao L, Blair IA, and Puré E. 2010. Hematopoietic stem cell function requires 12/15-lipoxygenase-dependent fatty acid metabolism. Blood 115: 5012–5022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Kinder M, Thompson JE, Wei C, Shelat SG, Blair IA, Carroll M, and Puré E. 2010. Interferon regulatory factor-8-driven myeloid differentiation is regulated by 12/15-lipoxygenase-mediated redox signaling. Exp Hematol 38: 1036–1046.e4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Mishra BB, Lovewell RR, Olive AJ, Zhang G, Wang W, Eugenin E, Smith CM, Phuah JY, Long JE, Dubuke ML, et al. 2017. Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis. Nat. Microbiol 2: 17072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Iwanaga N, and Kolls JK. 2019. Updates on T helper type 17 immunity in respiratory disease. Immunology 156: 3–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Werner JL, Gessner MA, Lilly LM, Nelson MP, Metz AE, Horn D, Dunaway CW, Deshane J, Chaplin DD, Weaver CT, et al. 2011. Neutrophils produce interleukin 17A (IL-17A) in a dectin-1- and IL-23-dependent manner during invasive fungal infection. Infect. Immun 79: 3966–3977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Dioszeghy V, Rosas M, Maskrey BH, Colmont C, Topley N, Chaitidis P, Kühn H, Jones SA, Taylor PR, and O’Donnell VB. 2008. 12/15-Lipoxygenase regulates the inflammatory response to bacterial products in vivo. J. Immunol 181: 6514–6524. [DOI] [PubMed] [Google Scholar]
- 46.Middleton MK, Rubinstein T, and Puré E. 2006. Cellular and molecular mechanisms of the selective regulation of IL-12 production by 12/15-lipoxygenase. J. Immunol 176: 265–274. [DOI] [PubMed] [Google Scholar]
- 47.Serhan CN, and Levy BD. 2018. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J. Clin. Invest 128: 2657–2669. [DOI] [PMC free article] [PubMed] [Google Scholar]